#LCSM Chat Topic for 12/17: Reflecting on 2015, Projecting 2016 for the Lung Cancer Community

Some years are bigger than others, and by just about any measure, 2015 was a banner year for the lung cancer community. We saw new drug approvals for a wide range of lung cancer patients, including immunotherapy for patients with both squamous and non-squamous advanced NSCLC, as well as very recent approvals as holiday presents for patients with an EGFR mutation or ALK rearrangement. We saw many important trials in lung cancer become high priorities, a growing use of next generation sequencing to identify new targets, and new data and greater acceptance… Read More

#LCSM Chat 9/17 8pm ET: Surgery or Radiation for Early Staged, Operable Lung Cancer: Which Road Should I Take?

Surgery or Radiation for Early Staged, Operable Lung Cancer: Which Road Should I Take? By guest host Mara B. Antonoff, MD, and host David Tom Cooke, MD As a newly established group in the world of health care social media, the Thoracic Surgery Social Media Network (#TSSMN, @tssmn) is thrilled for the opportunity to cohost our first Tweet chat with #LCSM Chat. We are delighted at this collaboration, bringing together a number of key stakeholders in lung cancer and thoracic surgery, for an important discussion regarding the roles of surgical resection and… Read More

#LCSM Chat 7/30 8pm ET: What’s the Role Today of Whole Brain Radiation for #LungCancer with Brain Metastases?

by H. Jack West, MD Brain metastases are relatively common in lung cancer, seen in about 15% of cases, and the management of them is evolving as technology and our preferences change. For decades, whole brain radiation therapy (WBRT) was the only game in town and did a reasonable job controlling a problem that we couldn’t manage readily any other way – chemotherapy generally doesn’t penetrate well into the brain, and brain surgery is only a feasible option for one or a few brain metastases, not many. But over the past 10-15… Read More